−40.88 MGBP
12.68 MGBP
242.80 M
About PURETECH HEALTH PLC ORD GBP0.01
Sector
Industry
CEO
Bharatt M. Chowrira
Website
Headquarters
Boston
Founded
2015
ISIN
GB00BY2Z0H74
FIGI
BBG009F3HD28
PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others. The Internal segment focuses on immunological, fibrotic, and lymphatic system mechanisms. The Controlled Founded Entities segment is composed of the group’s subsidiaries that are currently consolidated operational subsidiaries that either have or have plans to hire independent management teams and currently have already raised, or are currently in the process of raising, third-party dilutive capital. The Non-Controlled Founded Entities segment includes companies wherein the group no longer holds majority voting control as a shareholder and no longer has the right to elect a majority of the members of the subsidiaries’ Board of Directors. The Parent Company and Other segment represents activities that are not directly attributable to the operating segments, such as the activities of the parent, corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PRTC is 210.00 GBX — it has increased by 0.48% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange PURETECH HEALTH PLC ORD GBP0.01 stocks are traded under the ticker PRTC.
PURETECH HEALTH PLC ORD GBP0.01 is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for PURETECH HEALTH PLC ORD GBP0.01 has a max estimate of 6.20 GBX and a min estimate of 4.60 GBX.
PRTC earnings for the last quarter are −0.06 GBX whereas the estimation was 0.03 GBX which accounts for −329.41% surprise. Estimated earnings for the next quarter are 0.00 GBX. See more details about PURETECH HEALTH PLC ORD GBP0.01 earnings.
PURETECH HEALTH PLC ORD GBP0.01 revenue for the last quarter amounts to 7.11 M GBX despite the estimated figure of 6.45 M GBX. In the next quarter revenue is expected to reach 86.03 M GBX.
Yes, you can track PURETECH HEALTH PLC ORD GBP0.01 financials in yearly and quarterly reports right on TradingView.
PRTC stock has fallen by 2.33% compared to the previous week, the month change is a 1.87% fall, over the last year PURETECH HEALTH PLC ORD GBP0.01 has showed a 4.33% decrease.
Like other stocks, PRTC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PURETECH HEALTH PLC ORD GBP0.01 stock right from TradingView charts — choose your broker and connect to your account.